We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effects of Naproxen on Physical Performance

This study has been terminated.
(Study never initiated.)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00410995
First Posted: December 13, 2006
Last Update Posted: October 11, 2007
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
University of Oklahoma
December 12, 2006
December 13, 2006
October 11, 2007
May 2004
Not Provided
Effects on physical performance in terms of maximum oxygen consumption
Same as current
Complete list of historical versions of study NCT00410995 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Effects of Naproxen on Physical Performance
Effects of Naproxen on Physical Performance
The purpose of this study is to determine the effect of daily use of Naproxen (a commonly used over-the-counter NSAID) on the physical performance of athletes, as measured by maximum oxygen consumption.
Not Provided
Interventional
Phase 4
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Healthy
Drug: Naproxen
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Terminated
40
August 2006
Not Provided

Inclusion Criteria:

  1. Age equal to or greater than18 years of age
  2. No history of allergy or adverse reaction to any NSAID
  3. No use of any NSAID in past 2 weeks
  4. No history of peptic ulcer disease (PUD), gastroesophageal disease (GERD), or gastritis
  5. No major medical history including but not limited to diabetes, hypertension, asthma, kidney disease and coronary artery disease
  6. Currently not taking any medication including oral contraceptives

Exclusion Criteria:

  1. Age < 18 years of age
  2. History of allergy or adverse reaction to any NSAID
  3. Use of any NSAID in past 2 weeks
  4. History of a bleeding disorder
  5. History of PUD, GERD, or gastritis
  6. Pregnant
  7. A medical history of diabetes, hypertension, asthma, kidney disease or coronary artery disease
  8. Taking any medication including oral contraceptives
Sexes Eligible for Study: All
18 Years to 30 Years   (Adult)
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT00410995
11186
Not Provided
Not Provided
Not Provided
Not Provided
University of Oklahoma
Not Provided
Principal Investigator: LaMont Cavanagh, MD University of Oklahoma-Tulsa
University of Oklahoma
October 2007

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP